Spectranetics Corp (NASDAQ: SPNC) and Cutera (NASDAQ:CUTR) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends.
Insider & Institutional Ownership
92.0% of Spectranetics Corp shares are held by institutional investors. Comparatively, 84.4% of Cutera shares are held by institutional investors. 3.7% of Spectranetics Corp shares are held by company insiders. Comparatively, 11.6% of Cutera shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Risk and Volatility
Spectranetics Corp has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500. Comparatively, Cutera has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500.
Earnings & Valuation
This table compares Spectranetics Corp and Cutera’s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| Spectranetics Corp | N/A | N/A | N/A | ($1.59) | -24.18 |
| Cutera | $133.84 million | 3.53 | $7.29 million | $0.48 | 70.31 |
Cutera has higher revenue and earnings than Spectranetics Corp. Spectranetics Corp is trading at a lower price-to-earnings ratio than Cutera, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Spectranetics Corp and Cutera’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Spectranetics Corp | -32.93% | -194.18% | -23.25% |
| Cutera | 5.07% | 11.64% | 7.61% |
Analyst Recommendations
This is a summary of current recommendations and price targets for Spectranetics Corp and Cutera, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Spectranetics Corp | 0 | 8 | 0 | 0 | 2.00 |
| Cutera | 0 | 0 | 4 | 0 | 3.00 |
Spectranetics Corp currently has a consensus price target of $34.14, indicating a potential downside of 11.20%. Cutera has a consensus price target of $34.67, indicating a potential upside of 2.72%. Given Cutera’s stronger consensus rating and higher probable upside, analysts clearly believe Cutera is more favorable than Spectranetics Corp.
Summary
Cutera beats Spectranetics Corp on 9 of the 11 factors compared between the two stocks.
About Spectranetics Corp
The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads. Its geographic segments are U.S. Medical and International Medical. Its product offerings in U.S. Medical segment include medical devices used in minimally invasive procedures within the cardiovascular system, including fiber-optic devices and non-fiber-optic products (disposables), an excimer laser system (equipment) and the service of the excimer laser system (service). Its products are used in multiple vascular procedures, including peripheral atherectomy, crossing arterial blockages, coronary atherectomy and thrombectomy. Its International Medical segment is primarily engaged in distribution activities.
About Cutera
Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. The Company also offers products, such as CoolGlide that includes CV, Excel and Vantage; Solera that includes Titan S, ProWave 770, OPS 600, LP560, AcuTip 500, Titan V/XL and LimeLight, and a third-party sourced system, myQ for the Japanese market.
Receive News & Ratings for Spectranetics Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectranetics Corp and related companies with MarketBeat.com's FREE daily email newsletter.
